24 julio 2015
Drugs targeting the lymphotoxin-beta receptor may improve liver cancer treatment, a new study suggests. The findings could provide new treatment strategies for the disease, which is the third leading cause of cancer-related deaths worldwide.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/fPQo4bFz_rc» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/fPQo4bFz_rc/150723211150.htm
